Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo
- 5 July 2009
- journal article
- Published by Elsevier BV in Virology
- Vol. 389 (1-2), 108-121
- https://doi.org/10.1016/j.virol.2009.04.001
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Toward an AIDS VaccineScience, 2008
- Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cellsThe Journal of Experimental Medicine, 2008
- IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infectionThe Journal of Experimental Medicine, 2008
- Antibody-Based HIV-1 Vaccines: Recent Developments and Future DirectionsPLoS Medicine, 2007
- HIV-1 gp120 Mannoses Induce Immunosuppressive Responses from Dendritic CellsPLoS Pathogens, 2007
- Cytomegalovirus exploits IL-10–mediated immune regulation in the salivary glandsThe Journal of Experimental Medicine, 2007
- Noninfectious entry of HIV-1 into peripheral and brain macrophages mediated by the mannose receptorProceedings of the National Academy of Sciences, 2007
- Interleukin-10 determines viral clearance or persistence in vivoNature Medicine, 2006
- Carbohydrate specificities of the murine DC-SIGN homologue mSIGNR1Immunobiology, 2005
- Interaction of Leishmania parasites with dendritic cells and its functional consequencesImmunobiology, 2004